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summarizes their genetic characteristics, 
inheritance patterns, and the most pecu-
liar clinical manifestations. The recognition 
of AIDs derives from the combination of 
clinical data, evaluation of acute phase reac-
tants, clinical efficacy in response to specific 
drugs, and identification of specific muta-
tions in the causative genes (Federici et al., 
2006; Gattorno et al., 2008; Cantarini et al., 
2010a, 2011, 2012a,b; Muscari et al., 2012). 
Genetic testing remains a feasible tool to 
corroborate the clinical diagnosis of AIDs.
Most of these disorders are manifest in 
childhood, but a certain number of patients 
may experience disease onset during adult-
hood. To date, among monogenic AIDs a 
late disease onset has been described in 
FMF (Sohar et al., 1967; Sayarlioglu et al., 
2005; Cantarini et al., 2010b), TRAPS 
(Aksentijevich et al., 2001; Dodé et al., 2002; 
Aganna et al., 2003; Cantarini et al., 2012c), 
CAPS (Vitale et al., 2012), and NLRP12AD 
(Borghini et al., 2011).
Adult-onset FMF is fairly rare, how-
ever it has been reported as late as age 65 
(Cantarini et al., 2010b), and advanced 
age is not an exclusion criterion (Livneh 
et al., 1997): this picture is mainly related 
to low-penetrance mutations, giving rise to 
a milder disease, generally similar to that of 
younger patients (Sayarlioglu et al., 2005).
On the contrary, a more significant vari-
ability in terms of clinical phenotype may 
be observed in TRAPS (Aksentijevich et al., 
2001; Dodé et al., 2002; Aganna et al., 2003; 
Ravet et al., 2006; Cantarini et al., 2009, 
2010c,d,e,f,g; Rigante et al., 2011; Brizi 
et al., 2012): this heterogeneity is largely 
related to the wide spectrum of known 
TNFRSF1A mutations, which can be distin-
guished into high-penetrance and low-pen-
etrance variants (Touitou et al., 2004). As 
in FMF, adult-onset of symptoms is usually 
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Autoinflammatory disorders (AIDs) are a 
group of inherited diseases of innate immu-
nity, characterized by seemingly unpro-
voked inflammation recurring with variable 
rhythmicity and involving skin, serosal 
membranes, synovial membranes, and gas-
trointestinal tube, with reactive amyloidosis 
as a potential severe long-term complication 
(Touitou and Koné-Paut, 2008). They can 
be categorized in hereditary monogenic dis-
orders and multi-factorial polygenic disor-
ders, encompassing an expanding number 
of conditions, as the well-known periodic 
fever, aphthosis, pharyngitis, and adenitis 
(PFAPA) syndrome (Masters et al., 2009).
Monogenic AIDs are caused by muta-
tions in genes encoding proteins involved 
in the regulation or activation of the 
inflammatory response, and include 
familial Mediterranean fever (FMF), 
tumor necrosis factor receptor-associated 
periodic syndrome (TRAPS), mevalonate 
kinase deficiency syndrome, the family of 
cryopyrin-associated periodic syndromes 
(CAPS), which in turn include familial 
cold autoinflammatory syndrome (FCAS), 
Muckle–Wells syndrome and neonatal 
onset multisystem inflammatory disease, 
NLRP12-associated autoinflammatory 
disorder (NLRP12AD), PAPA (pyogenic 
arthritis, pyoderma gangrenosum, acne) 
syndrome, Majeed’s syndrome, deficiency 
of interleukin-1 receptor antagonist, and – 
lastly – Blau’s syndrome. Recurrent multi-
district inflammatory flares, which typically 
alternate with symptom-free intervals 
characterized by complete well-being and 
normalization of acute phase reactants, are 
the most striking marker of AIDs. The vast 
majority of these conditions are related to 
the activation of the interleukin-1 pathway, 
which results in a unifying common patho-
genetic mechanism (Rigante, 2012). Table 1 
related to low-penetrance mutations, which 
are associated with feeble clinical signs and 
a lower risk of amyloidosis (Aksentijevich 
et al., 2001; Dodé et al., 2002; Aganna 
et al., 2003). In addition, TRAPS patients 
carrying low-penetrance TNFRSF1A vari-
ants may show atypical clinical manifes-
tations and symptoms that mimic other 
AIDs and/or autoimmune diseases, such 
as idiopathic recurrent acute pericardi-
tis, thus hindering differential diagnosis 
(Cantarini et al., 2009, 2010d,e,g, 2012a; 
Rigante et al., 2011). These alleles have also 
been described in patients with recurrent 
inflammatory attacks who lack the most 
typical TRAPS manifestations, even when 
the duration of fever episodes is short and 
might resemble FMF, and even in healthy 
controls (Dodé et al., 2002; Ravet et al., 
2006; Cantarini et al., 2010a, 2011; Muscari 
et al., 2012). Their pathogenetic role and 
the genotype-phenotype correlation are 
still a huge matter of debate. Moreover, 
the absence of segregation in some families 
suggests the existence of other genes with a 
non-permissive power on AIDs expression 
(D’Osualdo et al., 2006).
On the other hand, CAPS are primar-
ily characterized by the onset of symptoms 
during early-infancy: nevertheless, we have 
recently described a case series of patients 
presenting FCAS-like symptoms, carrying 
the low-penetrance Q703K mutation in the 
NLRP3 gene, all characterized by disease 
onset during adulthood, and with clinical 
manifestations triggered or worsened by 
cold exposure (Vitale et al., 2012). Other 
NLRP3 mutations of unknown pathoge-
netic significance can also be found both 
in patients with recurrent inflamma-
tory attacks and in healthy controls: thus, 
their causal role remains doubtful and 
the question of whether these variants are 
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presence of low-penetrance mutations, giving 
nuanced clinical pictures in comparison with 
children, can be advocated. Low-penetrance 
mutations may also be responsible for oligo-
symptomatic diseases in some cases, and for 
the appearance of atypical clinical manifes-
tations in others, but may even function as 
susceptibility alleles to inflammation, rather 
than disease-associated mutations (Dodé 
et al., 2002; Ravet et al., 2006; Cantarini et al., 
2010d, 2012a). Indeed, we suggest caution in 
the interpretation of low-penetrance muta-
tions in probands with suspected AIDs in 
order to avoid false positive diagnoses and 
overtreatment, given the high frequency of 
healthy carriers and the influence of addi-
tional, still unknown, genetic and/or envi-
ronmental modifying factors.
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The differential diagnosis of AIDs can 
be complicated by PFAPA syndrome, which 
frequently occurs in pediatric patients. This 
syndrome does not have a documented 
genetic basis, and spontaneous resolution of 
fever episodes is commonly observed a few 
years after symptom onset (Marshall et al., 
1987, 1989; Thomas et al., 1999). Recent 
medical literature has included dozens of 
suspected cases in adults as well, suggest-
ing that it should be taken into considera-
tion also in adults (Cavuoto and Bonagura, 
2008; Padeh et al., 2008; Colotto et al., 2011; 
Cantarini et al., 2012d,e; Cazzato et al., 
2013).
In conclusion, although little data is avail-
able in the literature in comparison with the 
medical amount of clinical notes related to 
the pediatric population, the increasingly 
frequent reports of adult patients with AIDs 
is gradually allowing a more extensive and 
detailed information regarding their poten-
tial belated onset, genotype-phenotype cor-
relations, overall prognosis, and management 
of therapy. Both a delayed diagnosis during 
adulthood and adult-onset of symptoms are 
more and more observed: in these cases the 
 low-penetrance disease-associated muta-
tions or asymptomatic polymorphisms 
has been often raised (Aróstegui et al., 
2004; Aksentijevich et al., 2007; Verma 
et al., 2008). As in TRAPS, it has been sug-
gested that these alleles might exert a pos-
sible proinflammatory effect, causing an 
inflammatory phenotype in concomitance 
with other eventual environmental and/or 
genetic factors.
Also NLRP12AD has been shown to be 
characterized by neonatal or early-infancy 
onset (Goldbach-Mansky, 2012). However, 
Borghini et al. (2011) have recently 
described a 32-year-old woman found to 
be a carrier of the D294E NLRP12 muta-
tion: this patient experienced FCAS-like 
symptoms since the age of 20. In agree-
ment with these findings, we recently diag-
nosed a 27-year-old Caucasian woman 
with NLRP12AD and this patient carried 
the F402L mutation presenting a daily 
low-grade fever (<38°C) since the age 22 
(unpublished data). Hence, we underscore 
that patients carrying NLRP12 mutations 
might undoubtedly display a disease onset 
during adulthood.
Table 1 | Summary of the main genetic and clinical features of monogenic autoinflammatory disorders.
Disease Gene locus Protein Inheritance Prominent clinical features
FMF MEFV 16p13.3 Pyrin AR Fever, serositis, arthralgias or arthritides, erysipelas-like eruption on the legs, 
amyloidosis in untreated or resistant or non-compliant patients
TRAPS TNFRSF1A  
12p13
Tumor necrosis 
factor receptor 1
AD Fever, migrating muscle and joint involvement, arthralgias or arthritides, serosal 
involvement, steroid responsiveness of febrile attacks, conjunctivitis, periorbital 
edema, amyloidosis
MKD MVK 12q24 Mevalonate kinase AR Fever, polymorphous rash, arthralgias, abdominal pain, diarrhea, lymphnode 
enlargement, headache, splenomegaly, oral aphthosis
FCAS
NLRP3 1q44 Cryopyrin AD
Fever, cold-induced urticaria-like rash, conjunctivitis, arthralgias
MWS Fever, urticaria-like rash, conjunctivitis, arthralgias, neurosensorial deafness, amyloidosis
NOMID Fever, urticaria-like rash, uveitis, papilledema, deforming arthritides involving large 
joints (knees), aseptic chronic meningopathy, neurosensorial deafness, amyloidosis
NLRP12AD NLRP12 19q13 Monarch-1 AD Fever, arthralgias, cold-induced urticaria-like rash
BS NOD2 (CARD15) 
16q12.1–13
NOD2 AD Granulomatous dermatitis with ichthyosis-like changes, granulomatous 
polyarthritis, camptodactyly, recurrent panuveitis, intermittent fevers
PAPAs PSTPIP1 
15q24–q25.1
CD2 antigen-binding 
protein 1
AD Pyoderma gangrenosum, cystic acne, sterile pyogenic oligoarthritis
MS LPIN2 18p11.31 Lipin 2 AR Recurrent multifocal osteomyelitis, dyserythropoietic anemia, neutrophilic chronic 
dermatosis
DIRA IL1RN 2q14 Interleukin-1 
receptor antagonist
AR Multifocal osteomyelitis, diffuse pustular rash with neonatal onset
FMF, familial Mediterranean fever; TRAPS, tumor necrosis factor receptor-associated periodic syndrome; MKD, mevalonate kinase deficiency syndrome; FCAS, 
familial cold autoinflammatory syndrome; MWS, Muckle–Wells syndrome; NOMID, neonatal onset multisystem inflammatory disease; NLRP12AD, NLRP12-
associated autoinflammatory disorder; BS, Blau syndrome; PAPAs, pyogenic arthritis, pyoderma gangrenosum, acne syndrome; MS, Majeed syndrome; DIRA, 
deficiency of interleukin-1 receptor antagonist; AR, autosomal recessive; AD, autosomal dominant.
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